{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:53:25Z","timestamp":1784865205530,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Epilepsy Research Foundation in Finland"},{"name":"Brain Foundation of Finland"},{"name":"HUCH Research Grant"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.seizure.2017.12.007","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T20:02:18Z","timestamp":1514404938000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The essence of the first 2.5\u202fh in the treatment of generalized convulsive status epilepticus"],"prefix":"10.1016","volume":"55","author":[{"given":"Leena","family":"K\u00e4mppi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harri","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Kotisaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Soinila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.12.007_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1528-1167.2007.01359.x","article-title":"The epidemiology of convulsive and nonconvulsive status epilepticus","volume":"48","author":"Rosenow","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.007_bib0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.yebeh.2009.02.008","article-title":"Predictors of refractoriness in a Turkish status epilepticus data bank","volume":"14","author":"Agan","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"January","key":"10.1016\/j.seizure.2017.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.09.003","article-title":"Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review","volume":"93","author":"Neligan","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.12.007_bib0020","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status epilepticus severity score (STESS): A tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1528-1157.1996.tb00039.x","article-title":"Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus","volume":"37","author":"Krishnamurthy","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.007_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13054-017-1661-x","article-title":"Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study","volume":"21","author":"Kantanen","year":"2017","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.seizure.2017.12.007_bib0035","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","article-title":"Duration on refractory status epilepticus and outcome:Loss of prognostic utility after several hours","volume":"50","author":"Drislane","year":"2009","journal-title":"Epilepsia"},{"issue":"December (12)","key":"10.1016\/j.seizure.2017.12.007_bib0040","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/CCM.0b013e3181f859a6","article-title":"Functional outcome after convulsive status epilepticus","volume":"38","author":"Legriel","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.seizure.2017.12.007_bib0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9343(80)90415-5","article-title":"Status epilepticus: causes, clinical features and consequences in 98 patients","volume":"69","author":"Aminoff","year":"1980","journal-title":"The Am J Med"},{"key":"10.1016\/j.seizure.2017.12.007_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12028-014-0016-6","article-title":"Factors related to delays in pre-hospital management of status epilepticus","volume":"22","author":"K\u00e4mppi","year":"2015","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2017.12.007_bib0055","first-page":"591279","article-title":"Delays and factors related to cessation of generalized convulsive status epilepticus","volume":"2015","author":"K\u00e4mppi","year":"2015","journal-title":"Epilepsy Res Treat"},{"key":"10.1016\/j.seizure.2017.12.007_bib0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00415-008-0635-y","article-title":"Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts","volume":"255","author":"Vignatelli","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0065","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1528-1167.2010.02688.x","article-title":"Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice","volume":"51","author":"Aranda","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.007_bib0070","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1097\/CCM.0b013e3182591ff1","article-title":"Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation","volume":"40","author":"Kowalski","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.seizure.2017.12.007_bib0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1528-1157.1999.tb00775.x","article-title":"Depth of EEG suppression and outcome in barbiturate anesthetic treatment of status epilepticus","volume":"40","author":"krishnamurthy","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.007_bib0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the Evaluation and management of Status Epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2017.12.007_bib0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-012-6644-x","article-title":"Treatment deviating from guidelines does not influence status epilepticus prognosis","volume":"260","author":"Rossetti","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.24986","article-title":"Timing is everything: where status epilepticus treatment fails","volume":"82","author":"Hill","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12028-013-9862-x","article-title":"Soinila S.Analysis of the delay components in the treatment of status epilepticus","volume":"19","author":"K\u00e4mppi","year":"2013","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2017.12.007_bib0110","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1212\/WNL.0000000000001673","article-title":"Time from convulsive status epilepticus onset to anticonvulsant administration in children","volume":"84","author":"S\u00e1nchez Fern\u00e1ndez","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.007_bib0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/WNL.0b013e31825d6011","article-title":"Reducing in-hospital delay to 20\u202fminutes in stroke thrombolysis","volume":"79","author":"Meretoja","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.007_bib0120","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of Status epilepticus \u2212report of the ILAE task force oc classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.007_bib0125","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.12.007_bib0130","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","article-title":"Management of refractory status epilepticus in adults: still more questions than answers","volume":"10","author":"Rossetti","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00415-015-7992-0","article-title":"Association of seizure duration and outcome in refractory status epilepticus","volume":"263","author":"Mad\u017ear","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2017.12.007_bib0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yebeh.2016.07.018","article-title":"Benzodiazepine use in seizure emergencies: a systematic review","volume":"63","author":"Haut","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2017.12.007_bib0150","doi-asserted-by":"crossref","first-page":"544","DOI":"10.21037\/atm.2016.11.37","article-title":"Polytherapy as first-line in status epilepticus: should we change our practice? Time is brain!","volume":"4","author":"Radhakrishnan","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.seizure.2017.12.007_bib0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ccc.2012.11.007","article-title":"Pediatric intensive care treatment of uncontrolled status epilepticus","volume":"29","author":"Wilkes","year":"2013","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.seizure.2017.12.007_bib0160","doi-asserted-by":"crossref","first-page":"e0173539","DOI":"10.1371\/journal.pone.0173539","article-title":"Pre-hospital midazolam for benzodiazepine-treated seizures before and after the rapid anticonvulsant medication prior to arrival trial: a national observational cohort study","volume":"12","author":"Shtull-Leber","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.seizure.2017.12.007_bib0165","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1553-2712.2010.00828.x","article-title":"Sequential analysis of pretreatment delays in stroke thrombolysis","volume":"17","author":"Puolakka","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.seizure.2017.12.007_bib0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eplepsyres.2013.08.001","article-title":"Treatment and course of different subtypes of status epilepticus","volume":"107","author":"Rantsch","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.12.007_bib0175","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/ene.13359","article-title":"Distinguishing in-hospital and out-of-hospital status epilepticus: clinical implications from a 10-year cohort study","volume":"24","author":"Sutter","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03237.x","article-title":"Established status epilepticus treatment trial (ESETT)","volume":"52","author":"Cock","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.007_bib0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-017-0424-1","article-title":"Newer antiepileptic drugs in status epilepticus: prescription trends and outcomes in comparison with traditional agents","volume":"31","author":"Beuchat","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2017.12.007_bib0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11940-005-0035-x","article-title":"Treatment of convulsive and nonconvulsive status epilepticus","volume":"7","author":"Pang","year":"2005","journal-title":"Curr Treat Opinions Neurol"},{"key":"10.1016\/j.seizure.2017.12.007_bib0195","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/epi.13653","article-title":"Time to electroencephalography is independently associated with outcome in critically ill neonates and children","volume":"58","author":"S\u00e1nchez Fern\u00e1ndez","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.12.007_bib0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2014.06.023","article-title":"Seizure detection, seizure prediction, and closed-loop warning systems in epilepsy","volume":"37","author":"Ramgopal","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2017.12.007_bib0205","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4414\/smw.2009.12805","article-title":"Management and prognosis of status epilepticus according to hospital setting: a prospective study","volume":"139","author":"Rossetti","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.seizure.2017.12.007_bib0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eplepsyres.2011.01.006","article-title":"Propofol treatment in adult refractory status epilepticus: mortality risk and outcome","volume":"94","author":"Power","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2017.12.007_bib0215","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/epi.13837","article-title":"Costs, length of stay, and mortality of super-refractory status epilepticus: a population-based study from Germany","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117307100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117307100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:49:31Z","timestamp":1761011371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117307100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":43,"alternative-id":["S1059131117307100"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.12.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The essence of the first 2.5\u202fh in the treatment of generalized convulsive status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}